Jacopo Nori

Azienda Ospedaliero-Universitaria Careggi

Papers

1

Total Citations

29

H-Index

1

About

Jacopo Nori is a leading figure in the field of radiation oncology, with a focused expertise in breast cancer treatment and the innovative application of stereotactic radiosurgery. His major contributions center on the development and clinical validation of preoperative partial breast irradiation (PBI), a paradigm-shifting approach that treats a well-defined tumor target before surgical resection. As the principal investigator of the landmark phase II ROCK trial (NCT03520894), Nori demonstrated the safety and efficacy of preoperative robotic radiosurgery for early breast cancer patients. This pivotal study, published in 2022 and garnering 29 citations, has established a new framework for minimizing radiation exposure to healthy tissue while potentially improving local tumor control. Nori’s work bridges the gap between advanced radiation technology and surgical oncology, offering patients a less toxic, more precise treatment pathway. His research continues to shape clinical protocols and inspire further investigation into hypofractionated, targeted therapies, making him a key contributor to the evolution of modern breast cancer management.

Research Focus

Key Achievements

1
H-Index
1
Papers
29
Total Citations
29
Avg Citations/Paper
🏆 Most Cited Paper
Preoperative robotic radiosurgery for early breast cancer: Results of the phase II ROCK trial (NCT03520894)
29 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 20
🏛 Institutions: Azienda Ospedaliero-Universitaria Careggi

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago